CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-31 | KUMAR AMIT Chief Executive Officer | Sale | −11,800 | $3.57 | $42K | 461,925 |
| 2018-04-09 | WILLIAMS RICHARD H Director | Sale | −25,000 | $4.64 | $116K | 25,000 |
| 2016-08-24 | Titterton Lewis H jr Director | Sale | −210,000 | $3.10 | $651K | 287,437 |
| 2016-06-02 | HERMS HENRY P V.P., Finance & CFO | Sale | −500 | $3.23 | $2K | 22,125 |
| 2016-06-01 | HERMS HENRY P V.P., Finance & CFO | Sale | −1,000 | $3.27 | $3K | 23,125 |
| 2016-06-01 | HERMS HENRY P V.P., Finance & CFO | Sale | −500 | $3.28 | $2K | 22,625 |
| 2015-10-30 | HERMS HENRY P Vice President-Finance & CFO | Sale | −500 | $3.76 | $2K | 22,125 |
| 2015-10-29 | HERMS HENRY P Vice President-Finance & CFO | Sale | −800 | $3.73 | $3K | 22,625 |
| 2015-10-28 | HERMS HENRY P Vice President-Finance & CFO | Sale | −1,700 | $3.80 | $6K | 23,425 |
| 2015-10-27 | HERMS HENRY P Vice President-Finance & CFO | Sale | −1,000 | $3.79 | $4K | 25,125 |
Page 1 of 1 · 10 trades